维普中文期刊产品整合服务
10篇 您的检索式:作者名="Erster SH"
    题名 作者 年代 出处 被引量
1Polymerase chain reaction analysis of fragile X mutations显示文摘Erster SH Brown WT Goonewardena P 1992Hum Genet1992,90,12:1
2Polymerase chain reaction analysis of fragile X mutation显示文摘Erster SH Brown WT Goonewardena P 1992Hum gene1992,90,:1
3Delta P73,adominant negative inhibitor of wide type P53 and TAP73, is upregulated in human tumors显示文摘Zaika AI Slade N Erster SH 2002J Exp Med2002,196,6:1
4Np73, A dominant-negative inhibitor of wild-type p53 and TAp73 is up-regulated in human tumors显示文摘ZAIKA AI SLADE N ERSTER SH 2002J Exp Med2002,196,6:1
5DeltaNp73,a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors显示文摘Zaika AI Slade N Erster SH 2002J Exp Med2002,196,6:1
6DehaNp73, a domi- nant-negative inhibitor of wild-type p53 and TAp73, is up- regulated in human tumors 显示文摘Zaika AI Slade N Erster SH 2002J Exp Med2002,196,6:1
7DeltaNp73,a dominant-negative inhibitor of wild - type p53 and TAp73,is up - reg-ulated in human tumors 显示文摘Zaika AI Slade N Erster SH 2002J Exp Med2002,196,:1
8Polymerase chain reaction analysis of fragile X mutations显示文摘Erster SH Brown WT Goonewardena P 1992Hum Genet1992,90,12:1
9DeltaNp73, a dominant- negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors显示文摘Zaika AI Slade N Erster SH 2002J Exp Med2002,196,6:1
10Np73,a dominant-negative inhibitor of wild-type p53 and TAp73,is up-regulated in human tumors显示文摘Zaika AI Slade N Erster SH 2002J Exp Med2002,196,6:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费